feed,title,long_url,short_url
MedRxiv,"A Phase 2, randomized, double-blind, placebo-controlled multi-center trial sub-study for the clinical effects of paridiprubart treatment in hospitalized critically ill patients with COVID-19 ARDS",https://medrxiv.org/cgi/content/short/2023.09.21.23295853v1?rss=1,https://da.gd/vYIvz
